Global Biosimilars/follow-on-biologics Market Growth (Status and Outlook) 2022-2028

February 2022 | 85 pages | ID: GC33FDB319E5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Biosimilars/follow-on-biologics will have significant change from previous year. According to our (LP Information) latest study, the global Biosimilars/follow-on-biologics market size is USD million in 2022 from USD 9089.2 million in 2021, with a change of % between 2021 and 2022. The global Biosimilars/follow-on-biologics market size will reach USD 11310 million in 2028, growing at a CAGR of 3.2% over the analysis period.

The United States Biosimilars/follow-on-biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilars/follow-on-biologics market, reaching US$ million by the year 2028. As for the Europe Biosimilars/follow-on-biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biosimilars/follow-on-biologics players cover Novartis (Sandoz), Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/follow-on-biologics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Human growth hormone
• Erythropoietin
• Monoclonal antibodies
• Insulin
• Interferon
• Granulocyte-Colony Stimulating Factor
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Blood Disorders
• Oncology Diseases
• Chronic and Autoimmune Diseases
• Growth Hormone Deficiencies
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Novartis (Sandoz)
• Synthon Pharmaceuticals
• Teva Pharmaceutical Industries
• LG Life Sciences
• Celltrion Biocon
• Hospira
• Merck Serono (Merck)
• Biogen idec
• Genentech (Roche)

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biosimilars/follow-on-biologics Market Size 2017-2028
  2.1.2 Biosimilars/follow-on-biologics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biosimilars/follow-on-biologics Segment by Type
  2.2.1 Human growth hormone
  2.2.2 Erythropoietin
  2.2.3 Monoclonal antibodies
  2.2.4 Insulin
  2.2.5 Interferon
  2.2.6 Granulocyte-Colony Stimulating Factor
  2.2.7 Others
2.3 Biosimilars/follow-on-biologics Market Size by Type
  2.3.1 Biosimilars/follow-on-biologics Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
2.4 Biosimilars/follow-on-biologics Segment by Application
  2.4.1 Blood Disorders
  2.4.2 Oncology Diseases
  2.4.3 Chronic and Autoimmune Diseases
  2.4.4 Growth Hormone Deficiencies
  2.4.5 Others
2.5 Biosimilars/follow-on-biologics Market Size by Application
  2.5.1 Biosimilars/follow-on-biologics Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)

3 BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET SIZE BY PLAYER

3.1 Biosimilars/follow-on-biologics Market Size Market Share by Players
  3.1.1 Global Biosimilars/follow-on-biologics Revenue by Players (2020-2022)
  3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2020-2022)
3.2 Global Biosimilars/follow-on-biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY REGIONS

4.1 Biosimilars/follow-on-biologics Market Size by Regions (2017-2022)
4.2 Americas Biosimilars/follow-on-biologics Market Size Growth (2017-2022)
4.3 APAC Biosimilars/follow-on-biologics Market Size Growth (2017-2022)
4.4 Europe Biosimilars/follow-on-biologics Market Size Growth (2017-2022)
4.5 Middle East & Africa Biosimilars/follow-on-biologics Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Biosimilars/follow-on-biologics Market Size by Country (2017-2022)
5.2 Americas Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
5.3 Americas Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biosimilars/follow-on-biologics Market Size by Region (2017-2022)
6.2 APAC Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
6.3 APAC Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biosimilars/follow-on-biologics by Country (2017-2022)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biosimilars/follow-on-biologics by Region (2017-2022)
8.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
8.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET FORECAST

10.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2023-2028)
  10.1.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2023-2028)
  10.1.2 Americas Biosimilars/follow-on-biologics Forecast
  10.1.3 APAC Biosimilars/follow-on-biologics Forecast
  10.1.4 Europe Biosimilars/follow-on-biologics Forecast
  10.1.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast
10.2 Americas Biosimilars/follow-on-biologics Forecast by Country (2023-2028)
  10.2.1 United States Biosimilars/follow-on-biologics Market Forecast
  10.2.2 Canada Biosimilars/follow-on-biologics Market Forecast
  10.2.3 Mexico Biosimilars/follow-on-biologics Market Forecast
  10.2.4 Brazil Biosimilars/follow-on-biologics Market Forecast
10.3 APAC Biosimilars/follow-on-biologics Forecast by Region (2023-2028)
  10.3.1 China Biosimilars/follow-on-biologics Market Forecast
  10.3.2 Japan Biosimilars/follow-on-biologics Market Forecast
  10.3.3 Korea Biosimilars/follow-on-biologics Market Forecast
  10.3.4 Southeast Asia Biosimilars/follow-on-biologics Market Forecast
  10.3.5 India Biosimilars/follow-on-biologics Market Forecast
  10.3.6 Australia Biosimilars/follow-on-biologics Market Forecast
10.4 Europe Biosimilars/follow-on-biologics Forecast by Country (2023-2028)
  10.4.1 Germany Biosimilars/follow-on-biologics Market Forecast
  10.4.2 France Biosimilars/follow-on-biologics Market Forecast
  10.4.3 UK Biosimilars/follow-on-biologics Market Forecast
  10.4.4 Italy Biosimilars/follow-on-biologics Market Forecast
  10.4.5 Russia Biosimilars/follow-on-biologics Market Forecast
10.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast by Region (2023-2028)
  10.5.1 Egypt Biosimilars/follow-on-biologics Market Forecast
  10.5.2 South Africa Biosimilars/follow-on-biologics Market Forecast
  10.5.3 Israel Biosimilars/follow-on-biologics Market Forecast
  10.5.4 Turkey Biosimilars/follow-on-biologics Market Forecast
  10.5.5 GCC Countries Biosimilars/follow-on-biologics Market Forecast
10.6 Global Biosimilars/follow-on-biologics Forecast by Type (2023-2028)
10.7 Global Biosimilars/follow-on-biologics Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Novartis (Sandoz)
  11.1.1 Novartis (Sandoz) Company Information
  11.1.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered
  11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Novartis (Sandoz) Main Business Overview
  11.1.5 Novartis (Sandoz) Latest Developments
11.2 Synthon Pharmaceuticals
  11.2.1 Synthon Pharmaceuticals Company Information
  11.2.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered
  11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Synthon Pharmaceuticals Main Business Overview
  11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
  11.3.1 Teva Pharmaceutical Industries Company Information
  11.3.2 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered
  11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Teva Pharmaceutical Industries Main Business Overview
  11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
  11.4.1 LG Life Sciences Company Information
  11.4.2 LG Life Sciences Biosimilars/follow-on-biologics Product Offered
  11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 LG Life Sciences Main Business Overview
  11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
  11.5.1 Celltrion Biocon Company Information
  11.5.2 Celltrion Biocon Biosimilars/follow-on-biologics Product Offered
  11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Celltrion Biocon Main Business Overview
  11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
  11.6.1 Hospira Company Information
  11.6.2 Hospira Biosimilars/follow-on-biologics Product Offered
  11.6.3 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Hospira Main Business Overview
  11.6.5 Hospira Latest Developments
11.7 Merck Serono (Merck)
  11.7.1 Merck Serono (Merck) Company Information
  11.7.2 Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered
  11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Merck Serono (Merck) Main Business Overview
  11.7.5 Merck Serono (Merck) Latest Developments
11.8 Biogen idec
  11.8.1 Biogen idec Company Information
  11.8.2 Biogen idec Biosimilars/follow-on-biologics Product Offered
  11.8.3 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Biogen idec Main Business Overview
  11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
  11.9.1 Genentech (Roche) Company Information
  11.9.2 Genentech (Roche) Biosimilars/follow-on-biologics Product Offered
  11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Genentech (Roche) Main Business Overview
  11.9.5 Genentech (Roche) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biosimilars/follow-on-biologics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Human growth hormone
Table 3. Major Players of Erythropoietin
Table 4. Major Players of Monoclonal antibodies
Table 5. Major Players of Insulin
Table 6. Major Players of Interferon
Table 7. Major Players of Granulocyte-Colony Stimulating Factor
Table 8. Major Players of Others
Table 9. Biosimilars/follow-on-biologics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
Table 12. Biosimilars/follow-on-biologics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)
Table 15. Global Biosimilars/follow-on-biologics Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Biosimilars/follow-on-biologics Revenue Market Share by Player (2020-2022)
Table 17. Biosimilars/follow-on-biologics Key Players Head office and Products Offered
Table 18. Biosimilars/follow-on-biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Biosimilars/follow-on-biologics Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions (2017-2022)
Table 23. Americas Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Biosimilars/follow-on-biologics Market Size Market Share by Country (2017-2022)
Table 25. Americas Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
Table 27. Americas Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)
Table 29. APAC Biosimilars/follow-on-biologics Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Biosimilars/follow-on-biologics Market Size Market Share by Region (2017-2022)
Table 31. APAC Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
Table 33. APAC Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)
Table 35. Europe Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Biosimilars/follow-on-biologics Market Size Market Share by Country (2017-2022)
Table 37. Europe Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
Table 39. Europe Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Biosimilars/follow-on-biologics
Table 48. Key Market Challenges & Risks of Biosimilars/follow-on-biologics
Table 49. Key Industry Trends of Biosimilars/follow-on-biologics
Table 50. Global Biosimilars/follow-on-biologics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Biosimilars/follow-on-biologics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Biosimilars/follow-on-biologics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Application (2023-2028)
Table 56. Novartis (Sandoz) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 57. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered
Table 58. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Novartis (Sandoz) Main Business
Table 60. Novartis (Sandoz) Latest Developments
Table 61. Synthon Pharmaceuticals Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 62. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered
Table 63. Synthon Pharmaceuticals Main Business
Table 64. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Synthon Pharmaceuticals Latest Developments
Table 66. Teva Pharmaceutical Industries Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 67. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered
Table 68. Teva Pharmaceutical Industries Main Business
Table 69. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Teva Pharmaceutical Industries Latest Developments
Table 71. LG Life Sciences Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 72. LG Life Sciences Biosimilars/follow-on-biologics Product Offered
Table 73. LG Life Sciences Main Business
Table 74. LG Life Sciences Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. LG Life Sciences Latest Developments
Table 76. Celltrion Biocon Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 77. Celltrion Biocon Biosimilars/follow-on-biologics Product Offered
Table 78. Celltrion Biocon Main Business
Table 79. Celltrion Biocon Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Celltrion Biocon Latest Developments
Table 81. Hospira Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 82. Hospira Biosimilars/follow-on-biologics Product Offered
Table 83. Hospira Main Business
Table 84. Hospira Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Hospira Latest Developments
Table 86. Merck Serono (Merck) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 87. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered
Table 88. Merck Serono (Merck) Main Business
Table 89. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Merck Serono (Merck) Latest Developments
Table 91. Biogen idec Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 92. Biogen idec Biosimilars/follow-on-biologics Product Offered
Table 93. Biogen idec Main Business
Table 94. Biogen idec Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Biogen idec Latest Developments
Table 96. Genentech (Roche) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 97. Genentech (Roche) Biosimilars/follow-on-biologics Product Offered
Table 98. Genentech (Roche) Main Business
Table 99. Genentech (Roche) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Genentech (Roche) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biosimilars/follow-on-biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars/follow-on-biologics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biosimilars/follow-on-biologics Market Size Market Share by Type in 2021
Figure 7. Biosimilars/follow-on-biologics in Blood Disorders
Figure 8. Global Biosimilars/follow-on-biologics Market: Blood Disorders (2017-2022) & ($ Millions)
Figure 9. Biosimilars/follow-on-biologics in Oncology Diseases
Figure 10. Global Biosimilars/follow-on-biologics Market: Oncology Diseases (2017-2022) & ($ Millions)
Figure 11. Biosimilars/follow-on-biologics in Chronic and Autoimmune Diseases
Figure 12. Global Biosimilars/follow-on-biologics Market: Chronic and Autoimmune Diseases (2017-2022) & ($ Millions)
Figure 13. Biosimilars/follow-on-biologics in Growth Hormone Deficiencies
Figure 14. Global Biosimilars/follow-on-biologics Market: Growth Hormone Deficiencies (2017-2022) & ($ Millions)
Figure 15. Biosimilars/follow-on-biologics in Others
Figure 16. Global Biosimilars/follow-on-biologics Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Biosimilars/follow-on-biologics Market Size Market Share by Application in 2021
Figure 18. Global Biosimilars/follow-on-biologics Revenue Market Share by Player in 2021
Figure 19. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Biosimilars/follow-on-biologics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Biosimilars/follow-on-biologics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Biosimilars/follow-on-biologics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Biosimilars/follow-on-biologics Value Market Share by Country in 2021
Figure 25. Americas Biosimilars/follow-on-biologics Consumption Market Share by Type in 2021
Figure 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application in 2021
Figure 27. United States Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Biosimilars/follow-on-biologics Market Size Market Share by Region in 2021
Figure 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application in 2021
Figure 33. China Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Biosimilars/follow-on-biologics Market Size Market Share by Country in 2021
Figure 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type in 2021
Figure 41. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application in 2021
Figure 42. Germany Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application in 2021
Figure 50. Egypt Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Biosimilars/follow-on-biologics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 59. United States Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 63. China Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 67. India Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 70. France Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 71. UK Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Biosimilars/follow-on-biologics Market Size 2023-2028 ($ Millions)